All participants were at least 40 years old and had a spirometrically-confirmed diagnosis of mild-to-moderate COPD. The primary endpoint was clinical cure at the end of therapy visit.

If your COPD symptoms are worse than usual, you may be experiencing a COPD exacerbation. Learn the warning signs and what to do about them.

Based off of the Rome severity classification for COPD exacerbations, more hospitalized patients with severe vs. mild exacerbation received mechanical ventilation and died over 3 years, according ...

In a study published in the journal Chest, the researchers retrospectively categorized 347 adults hospitalized with ECOPD using the Rome severity classifications of mild, moderate, and severe.

Learn what it means to have moderate COPD and how that influences your symptoms, treatment, and outlook.

All participants were at least 40 years old and had a spirometrically-confirmed diagnosis of mild-to-moderate COPD. The primary endpoint was clinical cure at the end of therapy visit.

Even patients with mild COPD exacerbations can benefit from antibiotics and systemic corticosteroids, a systematic review and meta-analysis suggests.

The use of antibiotics in combination with oral corticosteroids to treat patients with mild-to-moderate exacerbations of COPD is the subject of much clinical debate.

In a post-hoc analysis of the KRONOS study, Martinez and colleagues evaluated 1,896 patients with moderate, severe or very severe COPD to understand how triple therapy of BGF impacts the rate of ...

COPD is classified into four stages: mild, moderate, severe, and very severe. To determine where your COPD falls on this spectrum, your doctor will take a careful history, evaluate your symptoms ...

Time to first moderate or severe exacerbation longer with mepolizumab in patients with COPD, history of exacerbations, eosinophil count greater than or equal to 300 cells/µL ...

All participants were at least 40 years old and had a spirometrically-confirmed diagnosis of mild-to-moderate COPD. The primary endpoint was clinical cure at the end of therapy visit.